Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha
- PMID: 17491024
- DOI: 10.1074/jbc.M703224200
Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha
Abstract
The Wnt/beta-catenin pathway has been implicated in bone cell response to their mechanical environment. This response is the origin of the mechanism by which bone cells adjust bone architecture to maintain bone strength. Osteoporosis is the most widespread failure of this mechanism. The degree of osteoporotic bone loss in men and women is related to bio-available estrogen. Here we report that in osteoblastic ROS 17/2.8 cells and primary osteoblast cultures, a single short period of dynamic mechanical strain, as well as the glycogen synthase kinase-3beta (GSK-3beta) inhibitor LiCl, increased nuclear accumulation of activated beta-catenin and stimulated TCF/LEF reporter activity. This effect was blocked by the estrogen receptor (ER) modulators ICI 182,780 and tamoxifen and was absent in primary osteoblast cultures from mice lacking ERalpha. Microarray expression data for 25,000 genes from total RNA extracted from tibiae of wild-type mice within 24 h of being loaded in vivo showed differential gene regulation between loaded and contralateral non-loaded bones of 10 genes established to be involved in the Wnt pathway. Only 2 genes were involved in loaded tibiae from mice lacking ERalpha (ERalpha(-/-)). Together these data suggest that Wnt/beta-catenin signaling contributes to bone cell early responses to mechanical strain and that its effectiveness requires ERalpha. Reduced effectiveness of bone cell responses to bone loading, associated with estrogen-related decline in ERalpha, may contribute to the failure to maintain structurally appropriate bone mass in osteoporosis in both men and women.
Similar articles
-
ERβ induces the differentiation of cultured osteoblasts by both Wnt/β-catenin signaling pathway and estrogen signaling pathways.Exp Cell Res. 2015 Jul 1;335(1):107-14. doi: 10.1016/j.yexcr.2015.04.020. Epub 2015 May 7. Exp Cell Res. 2015. PMID: 25957463
-
A DNA binding mutation in estrogen receptor-α leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts.J Cell Biochem. 2012 Jul;113(7):2248-55. doi: 10.1002/jcb.24095. J Cell Biochem. 2012. PMID: 22573547 Free PMC article.
-
Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.J Biol Chem. 2015 Jul 17;290(29):18216-18226. doi: 10.1074/jbc.M114.629204. Epub 2015 May 14. J Biol Chem. 2015. PMID: 25975268 Free PMC article.
-
Estrogen receptor and Wnt signaling interact to regulate early gene expression in response to mechanical strain in osteoblastic cells.Biochem Biophys Res Commun. 2010 Apr 9;394(3):755-9. doi: 10.1016/j.bbrc.2010.03.065. Epub 2010 Mar 17. Biochem Biophys Res Commun. 2010. PMID: 20227388
-
Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.Calcif Tissue Int. 2013 Aug;93(2):121-32. doi: 10.1007/s00223-013-9749-z. Epub 2013 Jun 11. Calcif Tissue Int. 2013. PMID: 23748710 Review.
Cited by
-
Adjuvant Endocrine Therapy and Bone Health in Breast Cancer.Curr Osteoporos Rep. 2015 Oct;13(5):263-73. doi: 10.1007/s11914-015-0277-9. Curr Osteoporos Rep. 2015. PMID: 26209043 Review.
-
Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis.Biomolecules. 2024 Aug 8;14(8):970. doi: 10.3390/biom14080970. Biomolecules. 2024. PMID: 39199358 Free PMC article. Review.
-
Mechanical signals as anabolic agents in bone.Nat Rev Rheumatol. 2010 Jan;6(1):50-9. doi: 10.1038/nrrheum.2009.239. Nat Rev Rheumatol. 2010. PMID: 20046206 Free PMC article. Review.
-
ERα and Wnt/β‑catenin signaling pathways are involved in angelicin‑dependent promotion of osteogenesis.Mol Med Rep. 2019 May;19(5):3469-3476. doi: 10.3892/mmr.2019.9999. Epub 2019 Mar 1. Mol Med Rep. 2019. PMID: 30864714 Free PMC article.
-
Hypoxia Signaling in the Skeleton: Implications for Bone Health.Curr Osteoporos Rep. 2019 Feb;17(1):26-35. doi: 10.1007/s11914-019-00500-6. Curr Osteoporos Rep. 2019. PMID: 30725321 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources